Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.77
+0.25 (2.63%)
At close: Sep 26, 2025, 4:00 PM EDT
9.75
-0.02 (-0.21%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Zevra Therapeutics Employees
Zevra Therapeutics had 59 employees as of December 31, 2024. The number of employees decreased by 10 or -14.49% compared to the previous year.
Employees
59
Change (1Y)
-10
Growth (1Y)
-14.49%
Revenue / Employee
$1,051,186
Profits / Employee
-$66,237
Market Cap
548.44M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ZVRA News
- 9 days ago - Zevra Therapeutics Announces Upcoming Oral Presentation at the International Niemann-Pick Disease Alliance (INPDA) Meeting and Poster Presentations at the Child Neurology Society (CNS) Conference on MIPLYFFA® (arimoclomol) and OLPRUVA® (sodium phenylbutyrate) - GlobeNewsWire
- 23 days ago - Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors of Metabolism (ICIEM) - GlobeNewsWire
- 4 weeks ago - Zevra Therapeutics Announces Multiple Datasets on MIPLYFFA® (arimoclomol) to be Presented at the International Congress of Inborn Errors of Metabolism (ICIEM) - GlobeNewsWire
- 4 weeks ago - Zevra Therapeutics to Participate at Upcoming Investor Conferences in September - GlobeNewsWire
- 6 weeks ago - Zevra Therapeutics, Inc. (ZVRA) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Zevra Reports Second Quarter 2025 Financial Results and Corporate Update - GlobeNewsWire
- 7 weeks ago - Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call - GlobeNewsWire
- 2 months ago - Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C - GlobeNewsWire